Counteracting drug-induced obesity using glp-1 agonists

The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.

Saved in:
Bibliographic Details
Main Author BOCK CAMILLA,KNUDSEN SANNE MOELLER,RIMVALL KARIN
Format Patent
LanguageEnglish
Published 18.04.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
Bibliography:Application Number: CN200580014789